SCHEMBL31423928

SCHEMBL31423928

CCOC(C)n1cc(-c2ncnc(N)c2F)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 6/20 0.48
JAK1 P23458 5/20 0.46
TYK2 P29597 3/20 0.46
JAK3 P52333 3/20 0.46
MAP3K5 Q99683 3/20 0.36
CD274 Q9NZQ7 1/20 0.36
SIGMAR1 Q99720 1/20 0.34
LRRK2 Q5S007 1/20 0.33
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HDAC9 Q9UKV0 1/20 0.32
HDAC5 Q9UQL6 1/20 0.32
NCOR2 Q9Y618 1/20 0.32
MET P08581 1/20 0.31
BRD4 O60885 1/20 0.31
CFTR P13569 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29885909 0.85 JAK2 (0.44) JAK2JAK1TYK2JAK3MAP3K5
SCHEMBL23209401 0.85 JAK2 (0.44) JAK2JAK1TYK2JAK3MAP3K5
SCHEMBL30043068 0.85 JAK2 (0.48) JAK2JAK1TYK2JAK3MAP3K5
SCHEMBL23209359 0.85 JAK2 (0.48) JAK2JAK1TYK2JAK3MAP3K5
SCHEMBL31423892 0.84 JAK2 (0.43) JAK2JAK1TYK2JAK3MAP3K5
SCHEMBL31423990 0.84 JAK2 (0.42) JAK2JAK1TYK2JAK3MAP3K5
SCHEMBL24849568 0.83 JAK2 (0.45) JAK2JAK1TYK2JAK3MAP3K5
SCHEMBL31318300 0.82 JAK2 (0.44) JAK2JAK1TYK2JAK3MAP3K5
SCHEMBL31318305 0.82 JAK2 (0.44) JAK2JAK1TYK2JAK3MAP3K5
SCHEMBL31318301 0.81 JAK2 (0.44) JAK2JAK1TYK2JAK3MAP3K5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096061-A1 CDK2 INHIBITORS AND USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
WO-2025054386-A1 CDK2 INHIBITORS AND USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2025-03-13 WO disclosed